Istanbul Medipol University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Istanbul Turkey (2009)

Organization Overview

First Clinical Trial
2011
NCT05017467
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Ahmet Emir | Ayşegül BOSTAN | Farzin Hajebrahimi, PT, MSc | Health Sciences University | istanbul medipol university | Istanbul Medipol University | IstanbulMedipol University | Istanbul Medipol University Hospital | Istanbul Medipol University Medical School | İstanbul Medipol Üniversity,Medical School | Medipol University

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 2)

Back Pain (Phase 2)

Dental Pulp Diseases (Phase 4)

Fecal Incontinence (Phase 1)

Fissure in Ano (Phase 4)

Low Back Pain (Phase 2)

Pain, Postoperative (Phase 4)

Parkinson Disease (Phase 2)

Periodontitis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 65
  • # of Trial APIs: 35